Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1176 | 9333 | 32.9 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THYMIDYLATE SYNTHASE | authKW | 1136811 | 6% | 61% | 573 |
2 | THYMIDINE PHOSPHORYLASE | authKW | 885296 | 4% | 73% | 372 |
3 | 5 FLUOROURACIL | authKW | 861633 | 11% | 25% | 1073 |
4 | DIHYDROPYRIMIDINE DEHYDROGENASE | authKW | 852351 | 3% | 84% | 311 |
5 | CAPECITABINE | authKW | 415051 | 5% | 29% | 439 |
6 | OXALIPLATIN | authKW | 369730 | 5% | 23% | 502 |
7 | METASTATIC COLORECTAL CANCER | authKW | 358252 | 3% | 39% | 281 |
8 | LEUCOVORIN | authKW | 324876 | 2% | 43% | 230 |
9 | ADVANCED COLORECTAL CANCER | authKW | 268986 | 1% | 65% | 127 |
10 | FLUOROPYRIMIDINES | authKW | 267898 | 2% | 58% | 142 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 103193 | 54% | 1% | 5050 |
2 | Pharmacology & Pharmacy | 6458 | 17% | 0% | 1626 |
3 | Gastroenterology & Hepatology | 768 | 4% | 0% | 332 |
4 | Biochemistry & Molecular Biology | 555 | 11% | 0% | 1049 |
5 | Chemistry, Medicinal | 343 | 3% | 0% | 242 |
6 | Biophysics | 205 | 3% | 0% | 268 |
7 | Biochemical Research Methods | 123 | 2% | 0% | 208 |
8 | Medicine, Research & Experimental | 100 | 2% | 0% | 232 |
9 | Medical Laboratory Technology | 76 | 1% | 0% | 69 |
10 | Surgery | 63 | 4% | 0% | 362 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED ONCOL | 49783 | 9% | 2% | 849 |
2 | TOKUSHIMA | 29831 | 1% | 17% | 53 |
3 | ONCOPHARMACOL UNIT | 29214 | 0% | 31% | 29 |
4 | GERCOR | 26371 | 0% | 73% | 11 |
5 | CANC 2 | 18830 | 0% | 52% | 11 |
6 | DIGEST ONCOL UNIT | 16772 | 0% | 16% | 32 |
7 | MED ONCOL UNIT | 16128 | 1% | 5% | 98 |
8 | ONCOPHARMACOL | 14686 | 0% | 16% | 28 |
9 | ONCOL | 14206 | 6% | 1% | 569 |
10 | UNITA CHEMIOTER IA | 13079 | 0% | 100% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL COLORECTAL CANCER | 98132 | 1% | 25% | 119 |
2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 38932 | 3% | 4% | 297 |
3 | ANNALS OF ONCOLOGY | 24908 | 3% | 3% | 252 |
4 | JOURNAL OF CLINICAL ONCOLOGY | 15541 | 3% | 2% | 281 |
5 | ANTI-CANCER DRUGS | 15208 | 1% | 4% | 124 |
6 | EUROPEAN JOURNAL OF CANCER | 14989 | 2% | 2% | 216 |
7 | ANTICANCER RESEARCH | 12922 | 3% | 1% | 279 |
8 | ONCOLOGY | 11783 | 1% | 3% | 120 |
9 | CANCER TREATMENT REPORTS | 11341 | 1% | 4% | 88 |
10 | ONCOLOGY-NEW YORK | 10789 | 1% | 5% | 70 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMIDYLATE SYNTHASE | 1136811 | 6% | 61% | 573 | Search THYMIDYLATE+SYNTHASE | Search THYMIDYLATE+SYNTHASE |
2 | THYMIDINE PHOSPHORYLASE | 885296 | 4% | 73% | 372 | Search THYMIDINE+PHOSPHORYLASE | Search THYMIDINE+PHOSPHORYLASE |
3 | 5 FLUOROURACIL | 861633 | 11% | 25% | 1073 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
4 | DIHYDROPYRIMIDINE DEHYDROGENASE | 852351 | 3% | 84% | 311 | Search DIHYDROPYRIMIDINE+DEHYDROGENASE | Search DIHYDROPYRIMIDINE+DEHYDROGENASE |
5 | CAPECITABINE | 415051 | 5% | 29% | 439 | Search CAPECITABINE | Search CAPECITABINE |
6 | OXALIPLATIN | 369730 | 5% | 23% | 502 | Search OXALIPLATIN | Search OXALIPLATIN |
7 | METASTATIC COLORECTAL CANCER | 358252 | 3% | 39% | 281 | Search METASTATIC+COLORECTAL+CANCER | Search METASTATIC+COLORECTAL+CANCER |
8 | LEUCOVORIN | 324876 | 2% | 43% | 230 | Search LEUCOVORIN | Search LEUCOVORIN |
9 | ADVANCED COLORECTAL CANCER | 268986 | 1% | 65% | 127 | Search ADVANCED+COLORECTAL+CANCER | Search ADVANCED+COLORECTAL+CANCER |
10 | FLUOROPYRIMIDINES | 267898 | 2% | 58% | 142 | Search FLUOROPYRIMIDINES | Search FLUOROPYRIMIDINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LIEKENS, S , BRONCKAERS, A , GAGO, F , BALZARINI, J , (2009) THE DUAL ROLE OF THYMIDINE PHOSPHORYLASE IN CANCER DEVELOPMENT AND CHEMOTHERAPY.MEDICINAL RESEARCH REVIEWS. VOL. 29. ISSUE 6. P. 903 -953 | 260 | 72% | 70 |
2 | VAN KUILENBURG, ABP , (2004) DIHYDROPYRIMIDINE DEHYDROGENASE AND THE EFFICACY AND TOXICITY OF 5-FLUOROURACIL.EUROPEAN JOURNAL OF CANCER. VOL. 40. ISSUE 7. P. 939-950 | 107 | 96% | 218 |
3 | MERCIER, C , CICCOLINI, J , (2006) PROFILING DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY IN PATIENTS WITH CANCER UNDERGOING 5-FLUOROURACIL/CAPECITABINE THERAPY.CLINICAL COLORECTAL CANCER. VOL. 6. ISSUE 4. P. 288-296 | 122 | 100% | 26 |
4 | MEULENDIJKS, D , CATS, A , BEIJNEN, JH , SCHELLENS, JHM , (2016) IMPROVING SAFETY OF FLUOROPYRIMIDINE CHEMOTHERAPY BY INDIVIDUALIZING TREATMENT BASED ON DIHYDROPYRIMIDINE DEHYDROGENASE ACTIVITY - READY FOR CLINICAL PRACTICE?.CANCER TREATMENT REVIEWS. VOL. 50. ISSUE . P. 23 -34 | 85 | 99% | 0 |
5 | CERSOSIMO, RJ , (2013) MANAGEMENT OF ADVANCED COLORECTAL CANCER, PART 1.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 70. ISSUE 5. P. 395 -406 | 81 | 98% | 11 |
6 | BERA, H , CHIGURUPATI, S , (2016) RECENT DISCOVERY OF NON-NUCLEOBASE THYMIDINE PHOSPHORYLASE INHIBITORS TARGETING CANCER.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 124. ISSUE . P. 992 -1003 | 93 | 85% | 0 |
7 | PLOYLEARMSAENG, SA , FUHR, U , JETTER, A , (2006) HOW MAY ANTICANCER CHEMOTHERAPY WITH FLUOROURACIL BE INDIVIDUALISED?.CLINICAL PHARMACOKINETICS. VOL. 45. ISSUE 6. P. 567-592 | 100 | 93% | 27 |
8 | PANCZYK, M , (2014) PHARMACOGENETICS RESEARCH ON CHEMOTHERAPY RESISTANCE IN COLORECTAL CANCER OVER THE LAST 20 YEARS.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 29. P. 9775 -9827 | 175 | 40% | 14 |
9 | MARING, JG , GROEN, HJM , WACHTERS, FM , UGES, DRA , DE VRIES, EGE , (2005) GENETIC FACTORS INFLUENCING PYRIMIDINE-ANTAGONIST CHEMOTHERAPY.PHARMACOGENOMICS JOURNAL. VOL. 5. ISSUE 4. P. 226-243 | 122 | 70% | 71 |
10 | VAN STAVEREN, MC , GUCHELAAR, HJ , VAN KUILENBURG, ABP , GELDERBLOM, H , MARING, JG , (2013) EVALUATION OF PREDICTIVE TESTS FOR SCREENING FOR DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY.PHARMACOGENOMICS JOURNAL. VOL. 13. ISSUE 5. P. 389-395 | 67 | 100% | 22 |
Classes with closest relation at Level 2 |